Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |